41.08
-1.71
(-4.00%)
At close: January 10 at 9:17:06 PM GMT+1
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
18,426,000.00
25,858,000.00
24,669,000.00
7,337,000.00
Total Liabilities Net Minority Interest
4,572,000.00
6,735,000.00
10,524,000.00
4,776,000.00
Total Equity Gross Minority Interest
13,854,000.00
19,123,000.00
14,145,000.00
2,561,000.00
Total Capitalization
13,854,000.00
19,123,000.00
14,145,000.00
2,561,000.00
Common Stock Equity
13,854,000.00
19,123,000.00
14,145,000.00
2,561,000.00
Capital Lease Obligations
1,243,000.00
1,200,000.00
916,000.00
237,000.00
Net Tangible Assets
13,758,000.00
19,123,000.00
14,145,000.00
2,561,000.00
Working Capital
7,310,000.00
8,508,000.00
6,943,000.00
1,909,000.00
Invested Capital
13,854,000.00
19,123,000.00
14,145,000.00
2,561,000.00
Tangible Book Value
13,758,000.00
19,123,000.00
14,145,000.00
2,561,000.00
Total Debt
1,243,000.00
1,200,000.00
916,000.00
237,000.00
Share Issued
382,000.00
385,000.00
403,000.00
398,787.68
Ordinary Shares Number
382,000.00
385,000.00
403,000.00
398,787.68
12/31/2020 - 12/12/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
22UA.F BioNTech SE
120.20
+1.52%
ABVX.PA ABIVAX Société Anonyme
6.47
+2.21%
9LB.F Legend Biotech Corporation
33.00
+5.10%
7IZ.MU Ziccum AB
0.0298
-29.72%
9LB.DU Legend Biotech Corp
31.00
-1.27%
5KW.F SkinBioTherapeutics plc
0.1720
+1.18%
HQ1.MU Oruka Therapeutics Inc. R
18.60
0.00%
IKAP.MU Aurinia Pharmaceuticals Inc
8.14
0.00%
HDP1.F Arrowhead Pharmaceuticals, Inc.
18.30
-3.69%
ORN.F Oryzon Genomics S.A.
1.5020
+2.18%